NeuroSense Therapeutics Ltd. (NRSN)

Last Closing Price: 1.54 (2025-05-30)

Stock-Based Compensation (Quarterly)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

NeuroSense Therapeutics Ltd. (NRSN) Stock-Based Compensation data is not available.

Figures for fiscal quarter ending 2024-09-30
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
$0.79M
$0.07M
$0.20M
$0.98M
$3.78M
$0.02M
$0.02M
$3.80M
$-2.82M
$-2.82M
$-2.82M
19.81M
Cash Flow Statement Financials
--
--
--
--
--
--
Stock-Based Compensation
--
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--